Trusted Press Release Distribution   Join | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Polaris Market Research
www.polarismarketresearch.com
Likhil Gajbhiye
likhil.g@polarismarketresearch.com
1-646-568-9980
30 Wall Street 8th Floor New York City, NY 10005 United States


Bookmark and Share
Facial Injectable Market Size Historical Growth, Analysis, Opportunities and Forecast To 2026
The “Facial Injectable Market” Report provides a complete decision-making overview including definition, product specifications, market gains, key geographic regions and imminent Facial Injectable Market industry peers for 2018-2026.

BriefingWire.com, 9/13/2018 - The Global Facial Injectable Market is anticipated to reach over USD 18,819.04 Million by 2026 according to a new research published by Polaris Market Research.

Facial injectable products also called as dermal fillers are products that benefit in facial transformation. These facial injectable products are widely used to indulgence the early signs of age as well as wrinkles thereby increasing the visual attractiveness.

Request For Sample Of This Research Report @ www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market/request-for-free-sample

Factors such as the rise in demand to augment the visual look and growing popularity for negligibly intrusive procedures majorly drive the market. In addition, the rise in elderly population and introduction of improved facial injectable such as synthetic calcium hydroxyl apatite fillers further anticipated boosting the market growth. In recent time, growing demand for non-surgical processes for facial transformation and modification is gaining global admiration. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), 2017, non-surgical and surgical cosmetic techniques showed an overall rise of 9% from past years. Moreover, according to the same report in 2016, nonsurgical procedures including injectable accounted for approximately 8 million globally.

The global Facial Injectable Market is segmented on the basis of products, end users, and geography.

On the basis of products, the Global Facial Injectable Market is segmented into Dermal Fillers/Injectable Implants and Anti-aging/ Anti-wrinkle Injections. The Dermal Fillers/Injectable Implants is further segmented into Hyaluronic Acid, Collagen Fillers, and Synthetic Fillers such as Calcium hydroxylapatite and polymethyl methacrylate microspheres. The Anti-aging/ Anti-wrinkle Injections is further categorized into Botulinum toxin A and Poly-L-lactic acid (PLLA) micro particles. On the basis of products, the hyaluronic acid segment is estimated to dominate the market in 2017. Moreover, this segment is anticipated to show lucrative growth during the forecast period. Cumulative use of hyaluronic acid as a dermal filler in the cosmetic procedure is anticipated to support the market growth. Hyaluronic acid has become an important part of cosmetics and aesthetic surgeries due to its robust water retaining properties. In general, the cosmetic-grade hyaluronic acid has the lower molecular weight which further aids to retain water in the cells, releases antioxidants, form the deep penetration of the product in the epidermis, and delays the aging progression. On the basis of the end user, the global Facial Injectable Market is segmented into Hospitals, Dermatology Clinics, Beauty Clinics, and Dermatology Research Institutes. In 2017, hospital segment is estimated to dominate the global market.

Enquiry Before Buying @ www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market/inquire-before-buying

Some major key players in global Facial Injectable Market include Advanced Dermatology, Merz, Inc., Galderma Laboratories, L.P., ColBar Life Science Ltd., Allergan, Plc., Valeant Pharmaceuticals North America LLC., Sanofi Biosurgery Inc. (Sanofi), Anika Therapeutics, Inc., Suneva Medical, Inc. among others.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2013 Proserve Technology, Inc.